About Telesis Bio
Telesis Bio is a company based in San Diego (United States) founded in 2013.. Telesis Bio has raised $25 million across 2 funding rounds from investors including Oxford Finance, Broadoak Capital Partners and Novalis LifeSciences. Telesis Bio has completed 1 acquisition, including Eton Bioscience. Telesis Bio offers products and services including BioXp System, BioXp 3250 System, BioXp 9600 System, and Gibson SOLA. Telesis Bio operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Quanterix and Ginkgo Bioworks, among others.
- Headquarter San Diego, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Telesis Bio, Inc.
-
Annual Revenue
$27.51 M0.27as on Dec 31, 2023
-
Net Profit
$-47.72 M1.54as on Dec 31, 2023
-
EBITDA
$-31.05 M28.81as on Dec 31, 2023
-
Total Equity Funding
$25 M (USD)
in 2 rounds
-
Latest Funding Round
$28 M (USD), Post-IPO
May 31, 2023
-
Investors
Oxford Finance
& 4 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Telesis Bio
Telesis Bio is a publicly listed company on the OTC with ticker symbol TBIO in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Telesis Bio
Telesis Bio offers a comprehensive portfolio of products and services, including BioXp System, BioXp 3250 System, BioXp 9600 System, and Gibson SOLA. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Fully automated tool for DNA and mRNA synthesis in research labs
Compact system for gene assembly and amplification processes
Scalable device for large-scale DNA workflows
Technique for efficient DNA fragment assembly in experiments
Unlock access to complete
Funding Insights of Telesis Bio
Telesis Bio has successfully raised a total of $25M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $28 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $28.0M
-
First Round
First Round
(09 Sep 2019)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Post-IPO - Telesis Bio | Valuation |
investors |
|
| Sep, 2019 | Amount | Series A - Telesis Bio | Valuation | Northpond Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Telesis Bio
Telesis Bio has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Oxford Finance, Broadoak Capital Partners and Novalis LifeSciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and advisory services are provided for life sciences.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life sciences & tech sectors
|
Founded Year | Domain | Location | |
|
Venture debt firm focused on the life sciences sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Telesis Bio
Telesis Bio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Eton Bioscience. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
DNA sequencing products and genomic services are developed and provided.
|
2003 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Telesis Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Telesis Bio Comparisons
Competitors of Telesis Bio
Telesis Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Quanterix and Ginkgo Bioworks, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Telesis Bio
Frequently Asked Questions about Telesis Bio
When was Telesis Bio founded?
Telesis Bio was founded in 2013 and raised its 1st funding round 6 years after it was founded.
Where is Telesis Bio located?
Telesis Bio is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Telesis Bio?
Todd R Nelson is the current CEO of Telesis Bio.
Is Telesis Bio a funded company?
Telesis Bio is a funded company, having raised a total of $25M across 2 funding rounds to date. The company's 1st funding round was a Series A of $25M, raised on Sep 09, 2019.
What is the annual revenue of Telesis Bio?
Annual revenue of Telesis Bio is $27.51M as on Dec 31, 2023.
What does Telesis Bio do?
Online platform offering life sciences reagents and kits. The companys products include the BioXp system, BioXp kits, and Benchtop reagents. Also, it develops vaccines, therapeutics, and diagnostics to combat the COVID-19 pandemic.
Who are the top competitors of Telesis Bio?
What products or services does Telesis Bio offer?
Telesis Bio offers BioXp System, BioXp 3250 System, BioXp 9600 System, and Gibson SOLA.
Is Telesis Bio publicly traded?
Yes, Telesis Bio is publicly traded on OTC under the ticker symbol TBIO.
How many acquisitions has Telesis Bio made?
Telesis Bio has made 1 acquisition, including Eton Bioscience.
Who are Telesis Bio's investors?
Telesis Bio has 5 investors. Key investors include Oxford Finance, Broadoak Capital Partners, Novalis LifeSciences, Northpond Ventures, and M 185 Corporation.
What is Telesis Bio's ticker symbol?
The ticker symbol of Telesis Bio is TBIO on OTC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.